Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease.
about
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersCisapride: what can we learn from the rise and fall of a prokinetic?Impaired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux disease.Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease.
P2860
Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Cisapride inhibits meal-stimul ...... ro-oesophageal reflux disease.
@en
Cisapride inhibits meal-stimul ...... ro-oesophageal reflux disease.
@nl
type
label
Cisapride inhibits meal-stimul ...... ro-oesophageal reflux disease.
@en
Cisapride inhibits meal-stimul ...... ro-oesophageal reflux disease.
@nl
prefLabel
Cisapride inhibits meal-stimul ...... ro-oesophageal reflux disease.
@en
Cisapride inhibits meal-stimul ...... ro-oesophageal reflux disease.
@nl
P2093
P2860
P1476
Cisapride inhibits meal-stimul ...... ro-oesophageal reflux disease.
@en
P2093
Gardner JD
Miner PB Jr
Robinson M
Rodriguez-Stanley S
P2860
P304
P356
10.1046/J.1365-2036.2002.01342.X
P407
P577
2002-10-01T00:00:00Z